Search

This study aimed to compare grazing behavior of dairy cows with highly contrasting pasture allocation frequencies. The study ran from September 9, 2022, to December 2, 2022 (12 wk), during a time when daily pasture growth was expected to exceed daily herd intake. Three pasture allocation frequencies were compared, each with 11 spring-calving cows grazing a 4-ha farmlet. The allocations were high frequency rotational grazing (HFRG; 32.5 m2/cow per allocation and 4 allocations/d), rotational grazing with weekly allocations (7RG; 909 m2/cow per allocation and each allocated area continuously grazed over 7 d), and continuous grazing (CG; 1,818 m2/cow per allocation). Animal behavior was monitored using IceQube accelerometers (Peacock Technology) and CowManager ear tags (Agis Automatisering BV). Milk yield and composition were measured and pasture cover was estimated. Daily eating time was highest for CG animals, whereas lying time, lying bouts, and ruminating time were lowest, with no differences between HFRG and 7RG. There were no differences in fat- and protein-corrected milk yield between farmlets; however, estimated accumulated pasture yield was greater with more frequent allocations. Although milk production did not differ between treatment groups, this appeared to be achieved through greater eating times when allocated pasture less frequently, at the expense of time spent lying.

Abstract Background Coronavirus disease-19 (COVID-19) infection causes persistent health problems such as breathlessness, chest pain and fatigue, and therapies for the prevention and early treatment of post-COVID-19 syndromes are needed. Accordingly, we are investigating the effect of a resistance exercise intervention on exercise capacity and health status following COVID-19 infection. Methods A two-arm randomised, controlled clinical trial including 220 adults with a diagnosis of COVID-19 in the preceding 6 months. Participants will be classified according to clinical presentation: Group A, not hospitalised due to COVID but persisting symptoms for at least 4 weeks leading to medical review; Group B, discharged after an admission for COVID and with persistent symptoms for at least 4 weeks; or Group C, convalescing in hospital after an admission for COVID. Participants will be randomised to usual care or usual care plus a personalised and pragmatic resistance exercise intervention for 12 weeks. The primary outcome is the incremental shuttle walks test (ISWT) 3 months after randomisation with secondary outcomes including spirometry, grip strength, short performance physical battery (SPPB), frailty status, contacts with healthcare professionals, hospitalisation and questionnaires assessing health-related quality of life, physical activity, fatigue and dyspnoea. Discussion Ethical approval has been granted by the National Health Service (NHS) West of Scotland Research Ethics Committee (REC) (reference: GN20CA537) and recruitment is ongoing. Trial findings will be disseminated through patient and public forums, scientific conferences and journals. Trial registration ClinicialTrials.gov NCT04900961 . Prospectively registered on 25 May 2021